Literature DB >> 12003522

Synthesis and evaluation of keto-glutamine analogues as inhibitors of hepatitis A virus 3C proteinase.

Yeeman K Ramtohul1, Michael N G James, John C Vederas.   

Abstract

Hepatitis A virus (HAV) 3C enzyme is a picornaviral cysteine proteinase involved in the processing of the initially synthesized viral polyprotein and is therefore important for viral maturation and infectivity. Although it is a cysteine proteinase, this enzyme has a topology similar to those of the chymotrypsin-like serine proteinases. Since the enzyme recognizes peptide substrates with a glutamine residue at the P(1) site, a number of ketone-containing glutamine compounds analogous to nanomolar inhibitors of cathepsin K were synthesized and tested for inhibition against HAV 3C proteinase. In addition, a 3-azetidinone scaffold was incorporated into the glutamine fragment but gave only modest inhibition. However, introduction of a phthalhydrazido group alpha to the ketone moiety gave significantly better inhibitors with IC(50) values ranging from 13 to 164 microM, presumably due to the effect of intramolecular hydrogen bonding to the ketone. In addition, the tetrapeptide phthalhydrazide 24 was found to be a competitive reversible inhibitor (K(i) = 9 x 10(-6) M) and also showed no loss of inhibitory potency in the presence of dithiothreitol.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003522     DOI: 10.1021/jo0157831

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  11 in total

1.  Facile synthesis of optically active imidazole derivatives.

Authors:  Ales Marek; Jiri Kulhanek; Miroslav Ludwig; Filip Bures
Journal:  Molecules       Date:  2007-05-30       Impact factor: 4.411

Review 2.  Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.

Authors:  Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Masato Nakamura; Xia Jiang; Yuki Haga; Reina Sasaki; Osamu Yokosuka
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

3.  Dual modes of modification of hepatitis A virus 3C protease by a serine-derived beta-lactone: selective crystallization and formation of a functional catalytic triad in the active site.

Authors:  Jiang Yin; Ernst M Bergmann; Maia M Cherney; Manjinder S Lall; Rajendra P Jain; John C Vederas; Michael N G James
Journal:  J Mol Biol       Date:  2005-10-14       Impact factor: 5.469

4.  An episulfide cation (thiiranium ring) trapped in the active site of HAV 3C proteinase inactivated by peptide-based ketone inhibitors.

Authors:  Jiang Yin; Maia M Cherney; Ernst M Bergmann; Jianmin Zhang; Carly Huitema; Hanna Pettersson; Lindsay D Eltis; John C Vederas; Michael N G James
Journal:  J Mol Biol       Date:  2006-07-07       Impact factor: 5.469

5.  Toward development of generic inhibitors against the 3C proteases of picornaviruses.

Authors:  Kamalika Banerjee; Ruchika Bhat; V U Bhaskara Rao; Anshu Nain; Kartik Lakshmi Rallapalli; Sohona Gangopadhyay; R P Singh; Manidipa Banerjee; Bhyravabhotla Jayaram
Journal:  FEBS J       Date:  2018-12-10       Impact factor: 5.542

Review 6.  An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.

Authors:  Thanigaimalai Pillaiyar; Manoj Manickam; Vigneshwaran Namasivayam; Yoshio Hayashi; Sang-Hun Jung
Journal:  J Med Chem       Date:  2016-02-29       Impact factor: 7.446

7.  Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy.

Authors:  Arun K Ghosh; Kai Xi; Michael E Johnson; Susan C Baker; Andrew D Mesecar
Journal:  Annu Rep Med Chem       Date:  2007-02-01       Impact factor: 1.059

Review 8.  Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors.

Authors:  Abhik Paul; Arnab Sarkar; Sanjukta Saha; Avik Maji; Pritha Janah; Tapan Kumar Maity
Journal:  Bioorg Med Chem       Date:  2021-07-03       Impact factor: 3.641

Review 9.  Molecular biology and inhibitors of hepatitis A virus.

Authors:  Yannick Debing; Johan Neyts; Hendrik Jan Thibaut
Journal:  Med Res Rev       Date:  2013-05-30       Impact factor: 12.944

10.  A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase.

Authors:  Jiang Yin; Chunying Niu; Maia M Cherney; Jianmin Zhang; Carly Huitema; Lindsay D Eltis; John C Vederas; Michael N G James
Journal:  J Mol Biol       Date:  2007-06-08       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.